Follow
Hematologic Cancers
Hematologic Cancers: start in blood-forming tissue, such as the bone marrow and cells of the immune system and can affect the blood and lymph system. A few examples of hematologic cancers are leukemia, lymphoma, and multiple myeloma.
What's Popular in Hematologic Cancers
-
AUG 15, 2023Drug Discovery & Development
Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. A ...Sponsored By: Sino BiologicalAPR 24, 2023Clinical & Molecular DX
When triple-negative breast cancer patients took several prescriptions worth of antibiotics in the three years after the ...Written By: Carmen LeitchAPR 11, 2023Cancer
Monoclonal antibodies have revolutionized cancer therapy since their introduction as therapeutics in the field. To enhan ...Sponsored By: Sino BiologicalJAN 12, 2023Cancer
Hematopoiesis, a biological process resulting in the formation of new blood cells, occurs throughout our lifetime. ...Written By: Katie KokolusDEC 29, 2022Genetics & Genomics
Our body generates a lot of blood cells - on the order of billions of cells every day. Stem cells in the bone marrow giv ...Written By: Carmen Leitch
AUG 15, 2023
Drug Discovery & Development
Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. A
...
Sponsored By:
Sino Biological
APR 24, 2023
Clinical & Molecular DX
When triple-negative breast cancer patients took several prescriptions worth of antibiotics in the three years after the
...
Written By:
Carmen Leitch
APR 11, 2023
Cancer
Monoclonal antibodies have revolutionized cancer therapy since their introduction as therapeutics in the field. To enhan
...
Sponsored By:
Sino Biological
JAN 12, 2023
Cancer
Hematopoiesis, a biological process resulting in the formation of new blood cells, occurs throughout our lifetime.
...
Written By:
Katie Kokolus
DEC 29, 2022
Genetics & Genomics
Our body generates a lot of blood cells - on the order of billions of cells every day. Stem cells in the bone marrow giv
...
Written By:
Carmen Leitch
DEC 26, 2022
Immunology
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h
...
Written By:
Carmen Leitch
SEP 13, 2022
Cancer
Introduction Cancer is the second leading cause of death globally. According to estimates from the American Cancer Socie
...
Sponsored By:
Sino Biological
AUG 08, 2022
Immunology
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass
...
Sponsored By:
Slingshot Biosciences, Inc.
JUN 20, 2022
Cell & Molecular Biology
An image by Sachin H. Patel/Boston Children's Hospital shows embryonic multipotent progenitor cells in a mouse embryo's
...
Written By:
Carmen Leitch
-
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificSeptember 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificSeptember 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificMAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...MAR 23, 2023 | 8:00 AM
Date: March 23, 2023 Time: 8:00am (PDT), 11:00am (EDT), 8:00pm (CEST) Across clinical oncology applications, from molecular testing to cancer research the ability to identify potentially act...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...
MAR 23, 2023 | 8:00 AM
Date: March 23, 2023 Time: 8:00am (PDT), 11:00am (EDT), 8:00pm (CEST) Across clinical oncology applications, from molecular testing to cancer research the ability to identify potentially act...
JAN 25, 2023 | 8:00 AM
Date: January 25, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Allogeneic hematopoietic cell transplantation (HCT) is curative for hematological diseases; however, is also associated...
Speaker:
Ivan Pasic, Hon BSc, PhD, MD, FRCPC
, Dr. Frank (Fotios) Michelis
Sponsored By: Olink Proteomics
DEC 14, 2022 | 12:00 PM
C.E. CREDITS
Date: December 14, 2022 Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET) Adopting novel technologies is essential for improving patient outcomes, but the key to sustainable success is through...
OCT 19, 2022 | 10:00 AM
C.E. CREDITS
Date: October 19, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) In this webinar, we will introduce the generation and applications of Biocytogen’s severely immunodeficient (B-N...
APR 14, 2022 | 8:00 AM
Date: April 14, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Across oncology applications, from research to molecular testing and pharmaceutical development, the ability to identify...
-
Labroots is pleased to announce the 14th Annual Event in the Clinical Diagnostics & Research Virtual Event Series to be held on November 9th, 2023 packed with featured speakers....
Labroots is excited to announce the 15th Annual Event in the Clinical Diagnostics & Research Virtual Event Series! This event will again bring together clinicians, researchers, medical e...SEP 13, 2023 | 11:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...NOV 09, 2022 | 5:30 AM PSTC.E. CREDITS
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....SEP 20, 2023C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and compl...
Labroots is pleased to announce the 14th Annual Event in the Clinical Diagnostics & Research Virtual Event Series to be held on November 9th, 2023 packed with featured speakers....
Labroots is excited to announce the 15th Annual Event in the Clinical Diagnostics & Research Virtual Event Series! This event will again bring together clinicians, researchers, medical e...
SEP 13, 2023
| 11:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
NOV 09, 2022
| 5:30 AM PST
C.E. CREDITS
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
SEP 20, 2023
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and compl...
JAN 10, 2022
| 7:30 AM PST
Bionano Genomics is transforming the way the world sees the genome. The 2022 Symposium will feature usage of optical genome mapping in research, clinical research and clinical validation......
DEC 07, 2021
| 12:00 PM PST
Date: December 7, 2021 Time: 12:30-5:00 p.m. ET #NCATS10...
NOV 10, 2021
| 5:30 AM PST
C.E. CREDITS
Twelve years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event Series...
DAY 1: OCTOBER 13/14, DAY 2: NOVEMBER 9/10
Join us at IonWorld 2021, a virtual conference, where speakers will share their experiences in advancing clinical research using Ion Torrent™ Next-Generation Sequencing Solutions. Lear...